The serotonin receptor subtypes 2 comprise 5-HT 2A , 5-HT 2B , and 5-HT 2C , which are G␣ q -coupled receptors and display distinct pharmacological properties. Although co-expressed in some brain regions and involved in various neurological disorders, their functional interactions have not yet been studied. We report that 5-HT 2 receptors can form homo-and heterodimers when expressed alone or co-expressed in transfected cells. Coimmunoprecipitation and bioluminescence resonance energy transfer studies confirmed that 5-HT 2C receptors interact with either 5-HT 2A or 5-HT 2B receptors. Although heterodimerization with 5-HT 2C receptors does not alter 5-HT 2C G␣ q -dependent inositol phosphate signaling, 5-HT 2A or 5-HT 2B receptormediated signaling was totally blunted. This feature can be explained by a dominance of 5-HT 2C on 5-HT 2A and 5-HT 2B receptor binding; in 5-HT 2C -containing heterodimers, ligands bind and activate the 5-HT 2C protomer exclusively. This dominant effect on the associated protomer was also observed in neurons, supporting the physiological relevance of 5-HT 2 receptor heterodimerization in vivo. Accordingly, exogenous expression of an inactive form of the 5-HT 2C receptor in the locus ceruleus is associated with decreased 5-HT 2A -dependent noradrenergic transmission. These data demonstrate that 5-HT 2 receptors can form functionally asymmetric heterodimers in vitro and in vivo that must be considered when analyzing the physiological or pathophysiological roles of serotonin in tissues where 5-HT 2 receptors are co-expressed.
for other 5-HT receptors, including 5-HT 1A , 5-HT 1B , 5-HT 1D , 5-HT 4 , and 5-HT 7 receptor subtypes in heterologous expression systems (13, (17) (18) (19) (20) . In addition, there are observations suggesting that the 5-HT 2 receptor subfamily can form heterodimeric complexes with other types of GPCRs. For example, the formation of heterodimers has been reported for the 5-HT 2A with mGluR2, D 2 -dopamine, and CB1 receptors (21) (22) (23) , for 5-HT 2C with ghrelin receptors (GHS-R1a) (24) and MT2 receptor (25) , for 5-HT 1A with -opioid (26) and adenosine A 2A receptors (27) , and for 5-HT 2B with angiotensin AT1 receptors (28) .
As mentioned above, oligomerization can occur between receptors of different GPCR families (i.e. 5-HT and dopamine for example) but also within the same family. A seminal study reported the identification of the first heterodimer between the 5-HT 1B and 5-HT 1D receptor subtypes (18) . However, no significant pharmacological differences were reported between homo-and heterodimers for these closely related 5-HT receptor subtypes. Recently, a study identified other 5-HT receptor heterodimers with functional implication; heterodimers between 5-HT 1A and 5-HT 7 receptors have been reported to regulate GIRK channel activity in heterologous systems and in hippocampal neurons (29) . Heterodimerization was found to inhibit 5-HT 1A -mediated activation of G␣ i and GIRK channel activity, without affecting 5-HT 7 receptor-mediated signaling, indicating a unidirectional dominant effect of the 5-HT 7 protomer. Of note, cross-talks between 5-HT receptors have been reported without obligatory physical interaction. For instance, co-expression of the 5-HT 1B and 5-HT 2B receptors influences the internalization pathways and kinetics of both receptors without heterodimerization (i.e. lack of FRET signal) (30) .
To date, neither the basic pharmacological profiles of putative 5-HT 2 heterodimers nor their signaling properties have been characterized. We specifically addressed this issue here by studying the interactions between the three members of the 5-HT 2 subfamily and their functional consequences in vitro and in vivo. Using co-immunoprecipitation and bioluminescence resonance energy transfer (BRET) approaches, we found that 5-HT 2A , 5-HT 2B , and 5-HT 2C form heterodimers when co-expressed in heterologous expression systems. Although 5-HT 2Ccontaining heterodimers did not show alterations in coupling properties, the signaling of associated 5-HT 2A or 5-HT 2B protomers was blunted, whereas the 5-HT 2C protomer maintained its signaling properties. Moreover, no blunting occurred in 5-HT 2A/2B heterodimers. We next showed that this asymmetry in G␣ q protein activation was related to a dominant effect of the 5-HT 2C protomer on ligand binding to the other partner. Using AAV-mediated exogenous expression of a 5-HT 2C receptor-truncated C-tail mutant ) in brain regions expressing endogenous 5-HT 2A receptor, we also observed a blunting effect of this inactive 5-HT 2C receptor leading to a complete binding inhibition of the 5-HT 2A -selective ligand. Accordingly, this lack of ligand binding was associated with impaired 5-HT 2A -induced excitatory neurotransmission in neurons expressing the 5-HT 2Cinactive protomer.
Results

Interactions between 5-HT 2 receptors
The putative formation of heterodimers between 5-HT 2 receptor subtypes was investigated using BRET and co-immunoprecipitation experiments (Fig. 1) . The coding region of Renilla luciferase (Rluc, BRET donor) or the yellow variant of the green fluorescent protein (YFP, BRET acceptor), were fused in-phase downstream of the coding region of 5-HT 2A , 5-HT 2B , and 5-HT 2C receptors. Saturation BRET experiments were conducted in HEK293 cells co-transfected with constant amounts of BRET donor plasmids and increasing amounts of BRET acceptor plasmids. In case of a close proximity between the investigated partners, hyperbolic saturation of the BRET signal is expected (see under "Experimental procedures"). Hyperbolic curves were indeed obtained when 5-HT 2A or 5-HT 2C receptors were tested for self-association (5-HT 2A/2A and 5-HT 2C/2C , respectively, Fig. 1a ), confirming previous studies showing that these receptors are able to homodimerize in transfected cells (13, 14) . Noteworthy, the same experiment with 5-HT 2B BRET pairs led to a linear plot, consistent with a bystander (nonspecific) BRET and thus with the absence of selfassociation. Hyperbolic curves were also obtained with 5-HT 2A and 5-HT 2C BRET pairs (5-HT 2A/2C ), 5-HT 2B and 5-HT 2C BRET pairs (5-HT 2B/2C ), and 5-HT 2A and 5-HT 2B (5-HT 2A/2B ) BRET pairs ( Fig. 1b ), suggesting that 5-HT 2 receptors can form heterodimers in intact cells. BRET 50 values (values of YFP/Rluc for half-maximal BRET) reflect the propensity of association between the investigated proteins. Interestingly, BRET 50 values for heterodimeric association are significantly lower than those measured for homodimeric association of 5-HT 2 subtypes, suggesting that in native cells expressing more than one 5-HT 2 receptor subtype heterodimerization is favored over homodimerization (Fig. 1b ).
The physical interaction between these receptor subtypes was confirmed by co-immunoprecipitation studies in the same cells, using epitope (FLAG)-or GFP-tagged proteins ( Fig. 1c ). Consistent with BRET data, FLAG-5-HT 2C receptor coimmunoprecipitated with 5-HT 2A -GFP and 5-HT 2C -GFP receptors. In complementary experiments FLAG-5-HT 2B receptor co-immunoprecipitated with 5-HT 2A -GFP and 5-HT 2C -GFP receptors.
Impact of dimerization of 5-HT 2 receptors on signaling
We next examined the consequence of 5-HT 2 -receptor heterodimerization on agonist-induced G␣ q activation. The 5-HT 2 receptors consistently activate the PLC-␤ pathway in native tissues and heterologous cells (3, 12) . We first determined whether 5-HT 2 receptor signaling was altered when expressed in the presence of other 5-HT 2 receptors (Fig. 2 ). Dose-response curves of 5-HT 2 -mediated production of IP in response to 5-HT or the partial agonist DOI in cells expressing 5-HT 2A , 5-HT 2B , or 5-HT 2C receptors and in combination were analyzed using the operational model (31) to determine the G␣ q coupling efficiency of single receptors and heterodimers ( Fig. 2 ). No significant difference in G␣ q coupling efficiency as determined by the transduction coefficient (/K A ) (32) was found among the groups, supporting a lack of major difference in coupling efficiency between individual 5-HT 2 receptors to G␣ q activation and no modification of this coupling efficiency by heterodimers.
In the absence of highly selective, subtype-specific 5-HT 2 agonists, we next determined whether agonist-induced 5-HT 2 heterodimer signaling was altered in the presence of selective antagonist of the other protomer ( Fig. 5 ). Affinity and selectivity of antagonists were first tested in transfected cells to define the optimal concentration that nearly fully inhibits each individual receptor and to avoid cross-reactivity (100 nM, Fig. 3 ). and co-immunoprecipitation in living HEK293 cells. a, BRET proximity assays between homodimers of 5-HT 2A , 5-HT 2B , or 5-HT 2C receptors. HEK293 cells were co-transfected with plasmids coding for a constant amount of RLuc-5-HT 2A , RLuc-5-HT 2B or RLuc-5-HT 2C (BRET donors) and increasing concentrations of the corresponding YFP tagged 5-HT 2 homodimer (the BRET acceptor). b, BRET proximity assays between heterodimers of 5-HT 2A , 5-HT 2B , or 5-HT 2C receptors. HEK293 cells were co-transfected with plasmids coding for a constant amount of RLuc-5-HT 2A , RLuc-5-HT 2B , or RLuc-5-HT 2C (BRET donors) and increasing concentrations of YFP-tagged 5-HT 2 heterodimer (the BRET acceptor). For each heterodimers, BRET donor and acceptor were swapped as a control experiment (data not shown). Energy transfer was measured after addition of membrane-permeable luciferase substrate coelenterazine-h. The BRET signal was determined by calculating the ratio of light emitted at 530 nm and that emitted at 485 nm, subtypes in co-immunoprecipitation experiments. COS-7 cells were transfected with various combinations of plasmids coding for 5-HT 2A -YFP, 5-HT 2C -YFP, and FLAG epitope-tagged 5-HT 2B and 5-HT 2C , as indicated. Immunoprecipitation with a monoclonal anti-FLAG antibody-coated beads (EZview Red FLAG M2 affinity gel) was performed from 1 mg of protein of cell lysates. The presence of 5-HT 2 -GFP and 5-HT 2 -FLAG was revealed with anti-GFP and anti-FLAG antibodies, respectively. 100 g of protein of cell lysates were analyzed to determine receptor-GFP receptor-FLAG expression (input). White asterisk, IgG heavy chain. WB, Western blotting; IP, immunoprecipitation.
Dose-response curves of 5-HT 2 -mediated IP accumulation in response to 5-HT stimulation allowed the determination of the minimal agonist concentration inducing maximal IP response (1 M, Fig. 4a ). When expressed individually, 5-HT 2 receptors displayed significant 5-HT-stimulated IP production ( Fig. 5a ); in the presence of selective antagonists (MDL100970 for 5-HT 2A , RS127445 for 5-HT 2B , and RS102221 for 5-HT 2C receptors), the agonist-stimulated IP response was reduced to basal level in cells expressing the cognate 5-HT 2 receptor ( Fig. 5a ).
In the 5-HT 2A/2B heterodimers, the 5-HT 2A receptor contributed to the activation of the G␣ q /PLC-␤ pathway in response to agonist, as demonstrated by the inhibitory effect of MDL100907 ( Fig. 5a ); reciprocally, the 5-HT 2B receptor was also contributing to signaling when co-expressed with 5-HT 2A receptors, as demonstrated by the inhibitory effect of RS127445 ( Fig. 5a ). By contrast in the 5-HT 2B/2C heterodimers, only the 5-HT 2C receptors continued mediating signaling, because blocking selectively the 5-HT 2B receptors with RS127445 did not inhibit the 5-HT-mediated IP accumulation ( Fig. 5a ), although it can be blocked only by selective 5-HT 2C receptor antagonists RS102221 or SB242084 (Figs. 5a and 4, c and d).
The 5-HT 2A -mediated IP accumulation was similarly blunted by expression of the 5-HT 2C receptor, as MDL100907 had no significant inhibitory effect on IP production but RS102221 did (Fig. 5a ).
The same effect was reproduced for different agonists 5-HT or nor-(ϩ)-fenfluramine (NDF) (Fig. 4 , e and f) and in all tested cell lines, COS-7 ( Fig. 2 ), HEK293 (Figs. 4 -5), CHO ( Fig. 6c ), or LMTK ( Fig. 6, a and b) , and thus is likely independent of agonists or cell-specific effectors. Because it was shown above that under the same expression conditions these receptor isoforms constitute heterodimers, a plausible explanation for the observed effects is that heterodimerization with 5-HT 2C prevents the ability of 5-HT 2A or 5-HT 2B receptors to signal, whereas in the case of heterodimerization of 5-HT 2A with 5-HT 2B receptors, both 5-HT 2A and 5-HT 2B protomers contribute to signal.
These results are consistent with a model where in the 5-HT 2A/2C and 5-HT 2B/2C heterodimers, only the 5-HT 2C protomer couples to the G protein, while preventing coupling of the associated protomer. To investigate this issue, we co-expressed the 5-HT 2A or 5-HT 2B receptor with a 5-HT 2C receptor deleted for the C-terminal tail (5-HT 2C⌬Cter ) ( Fig. 5b ), a mutant receptor incapable of activating G␣ q and stimulating IP production in response to 5-HT stimulation ( Fig. 5b ). Confirming the hypothesis, in cells expressing 5-HT 2A/2C⌬Cter and 5-HT 2B/2C⌬Cter heterodimers, IP accumulation was dramatically reduced (Fig. 5b ). In addition, co-expressing 5-HT 2C receptors with 5-HT 2B⌬Cter , a 5-HT 2B receptor similarly deleted for the C-terminal tail and impaired for IP accumulation, had no impact on 5-HT 2C signaling ( Fig. 5b ) because it was still sensitive to RS102221, supporting that only the 5-HT 2C protomer couples to the G q protein. We confirmed the proper plasma membrane expression of the 5-HT 2C⌬Cter and 5-HT 2B⌬Cter receptor constructs compared with the respective WT form, using a radioligand binding assay on non-permeabilized cells. Expression of 5-HT 2B , 5-HT 2B⌬Cter , 5-HT 2C , or 5-HT 2C⌬Cter receptors in HEK cells leads to 37, 50, 20, and 53% of construct surface expression compared with total whole cell membrane expression (permeabilized cells), respectively, suggesting that ⌬Cter constructs are expressed properly at the cell membrane. Moreover, BRET assay confirms the ability of the two ⌬Cter constructs to associate with 5-HT 2A , 5-HT 2B , or 5-HT 2C protomers ( Fig. 7 , a-d). To confirm these findings, in cell expressing constant 5-HT 2B and variable amounts of 5-HT 2C receptors, the progressive decrease of 5-HT 2C expression level allowed the recovery of 5-HT 2B receptor-dependent signaling (the fraction of IP accumulation inhibited by the 5-HT 2B -selective RS127445), likely due to reduced formation of 5-HT 2B/2C heterodimers (Fig. 7e ).
Impact of dimerization on 5-HT 2 receptor-binding properties
The results above are thus consistent with a model where in A possibility is that the presence of a 5-HT 2C protomer is sufficient to compete with plasma membrane accessibility of either 5-HT 2A or 5-HT 2B protomers. Surface expression of 
Dimerization among 5-HT 2 receptor subtypes
both receptors was measured by cytometry using a Pacific Blueconjugated antibody directed against extracellular 3ϫFLAGtagged 5-HT 2 -YFP constructs, with YFP being intracellular and reflecting total expression of the receptor (Fig. 9 ). The ratio of cell-surface receptors over the total obtained (mean of Pacific Blue signal/mean of GFP) for each condition was normalized as the percentage of 5-HT 2A (Fig. 9 , a and b) or 5-HT 2B receptor alone. 5-HT 2A (Fig. 9c ) or 5-HT 2B (Fig. 9d ) receptors in cells co-transfected with 5-HT 2C receptors were not significantly different compared with control (single expression), although co-expression of 5-HT 2A receptors slightly increased cell-surface expression of 5-HT 2B receptors. Decreased ligand binding or G␣ q coupling of 5-HT 2A or 5-HT 2B receptors co-expressed with 5-HT 2C receptor cannot be explained by reduced cell-surface expression.
Heterodimer properties in vivo
The inhibitory role of 5-HT 2C on 5-HT 2A and 5-HT 2B receptor binding and coupling was next analyzed in neurons. Mouse prefrontal cortex (PFC) neurons, which have been shown to express 5-HT 2A receptors (33, 34) , were used as a model system. Accordingly, exogenous 5-HT 2C⌬Cter expression in PFC, upon infection with adeno-associated viruses carrying a 5-HT 2C⌬Cter construct (AAV-5-HT 2C⌬Cter ), was associated with an increase of [ 3 H]mesulergine able to bind to endogenous 5-HT 2A and exogenous 5-HT 2C⌬Cter receptors (Fig. 10a ). However, a dramatic inhibition of endogenous 5-HT 2A receptor-dependent ligand binding compared with AAV-mediated GFP expression was also observed (absence of MDL100907-induced [ 3 H]mesulergine displacement) ( Fig. 10a ). We then investigated whether the 5-HT 2C receptor was also able to suppress 5-HT 2A receptordependent signaling in vivo via heterodimerization. We thus used the same adenoviral delivery system to express the inactive 5-HT 2C⌬Cter protomer in adrenergic locus ceruleus (LC) neurons. Previous studies reported that the 5-HT 2 receptor agonist DOI decreases the firing rate of 5-HT neurons in the dorsal raphe (DR) nucleus (35, 36) . This inhibitory response was completely blunted in 5-Htr 2A
Ϫ/Ϫ mice and was attenuated (30%) by inducing the loss of noradrenergic neurons with the DSP4 neurotoxin (37) . Indeed, activation by DOI of 5-HT 2A receptors expressed on GABAergic interneurons of the LC (38, 39) decreased noradrenergic tone thereby limiting its excitatory influence on DR 5-HT neurons. A corollary of these functional interactions between monoaminergic neurons is a significant decrease of DR 5-HT neuronal activity. We then used this paradigm as a functional read-out for norepinephrine transmission upon expression of the functionally inactive 5-HT 2C⌬Cter protomer ( Fig. 10, b-d) . Bilateral stereotaxic injections of AAV-5-HT 2C⌬Cter IRES GFP or AAV GFP in the LC were performed 1 month before in vivo electrophysiological recordings of DR 5-HT neurons (Fig. 10b ). Mouse brains samples were examined to verify the distribution of adenovirus-encoded 5-HT 2C⌬Cter and GFP in the LC (Fig. 10c ). In mice injected with control AAV (AAV GFP), increasing DOI concentrations induced a progressive decrease of the firing rate of DR 5-HT neurons (Fig. 10d ), as observed by previous reports (37) . This inhibitory response was strongly reduced (50%) in AAV-5-HT 2C⌬Cter -injected mice (Fig. 10d ), consistent with an impaired signaling of 5-HT 2A receptors. These data indicate that 5-HT 2C⌬Cter receptors inhibit 5-HT 2A receptor-mediated signaling in neurons, likely via their heterodimerization with 5-HT 2A receptors.
Discussion
Our data demonstrate that 5-HT 2A , 5-HT 2B , and 5-HT 2C receptors heterodimers are favored and able to form in vitro and in vivo. Although heterodimerization with 5-HT 2C receptors does not apparently modify the coupling ability to the G␣ q pathway, it appears to blunt binding properties of 5-HT 2A and 5-HT 2B protomers. These findings can be interpreted as uni-directional dominance of 5-HT 2C over the two other protomers in 5-HT 2A/2C and 5-HT 2B/2C heterodimers. The masking effect exerted by the 5-HT 2C protomer is specific, because no similar functional consequences could be observed in 5-HT 2A/2B heterodimers. This dominance appears to be independent of ligands (agonists or antagonists), of the cell type or of the plasma membrane accessibility of the different protomers.
Uni-directional activating or inhibiting effects of protomers on ligand binding or coupling properties of the cognate partner were reported for few GPCR heterodimers (40) . For example, G protein coupling of angiotensin AT1 receptor is inhibited in AT1/AT2 or AT1/APJ (the receptor for apelin) heterodimers (41, 42) but not in AT1/5-HT 2B heterodimers (28) . In this context, impaired coupling can be caused by different mechanisms. Ligand occupancy of one protomer of the heterodimer can induce conformational changes of the binding pocket of the second protomer resulting in ligand binding inhibition (43) . The inhibitory effect of one protomer can also occur in the absence of its ligand. For example, the long C-terminal tail of the orphan receptor GPR50 indirectly prevents the binding of melatonin to the MT1 melatonin receptor in GPR50-MT1 heterodimers (44) .
Here, we show that 5-HT 2C⌬Cter , which lacks the capacity of activating G␣ q proteins, inhibits both G␣ q coupling and ligand binding of associated 5-HT 2 protomers. These data indicate that asymmetric "sequestration" of G␣ q by the C-terminal tail of the 5-HT 2C receptor does not account for the observed effect. Consistent with previous observations, showing that a 5-HT 2 protomer can promote conformational changes across asymmetrical dimer interface (45, 46) , 5-HT 2C -dependent inhibition of 5-HT 2A and 5-HT 2B protomer binding might occur via a similar mechanism.
Interestingly, when 5-HT 2C receptors were co-expressed with 5-HT 2A or 5-HT 2B receptors, binding and functional studies indicated the absence of 5-HT 2A -or 5-HT 2B -dependent sig- naling, consistent with the absence of 5-HT 2A or 5-HT 2B monomers or homodimers at the cell surface. The analysis of BRET 50 values in saturation BRET experiments, which reflect the propensity of association between protomers, suggests that in cells expressing simultaneously 5-HT 2C and another 5-HT 2 receptor isoform the heterodimers are more likely to form than homodimers or monomers, and our cytometry analysis revealed that there was no impact of plasma membrane accessibility of 5-HT 2 receptor protomers.
Although many reports addressing the capacity of GPCRs to form heterodimeric complexes were based on investigations performed in transfected cells, only a few studies could document the existence and the functional significance of these complexes in vivo (21, 29, 47) . Here, we show that the expression of exogenous 5-HT 2C⌬Cter receptors in PFC is associated with a dramatic inhibition of 5-HT 2A receptor-dependent ligand binding, suggesting that both receptors are able to form heterodimers in vivo. Accordingly, we found that virusmediated exogenous expression of the inactive protomer 5-HT 2C⌬Cter reduces 5-HT 2A receptor-dependent neuronal inhibition of DR 5-HT neurons. Altogether, these results support that 5-HT 2C receptors are able to form functional heterodimers with 5-HT 2A or 5-HT 2B receptors when co-expressed in neurons and pinpoint the physiological relevance of a putative switch in the pharmacological profile of these neurons, depending on 5-HT 2C expression levels.
In line with this hypothesis, a recent study showed that high phenotypic motor impulsivity was associated with a diminished PFC 5-HT 2A ⅐5-HT 2C receptor complex (8) . Independent findings about 5-HT 1A ⅐5-HT 7 heterodimers (29) demonstrated that heterodimerization markedly decreases the ability of the 5-HT 1A receptor to activate G-protein in hippocampal neurons. Interestingly, because 5-HT 7 receptor expression decreases during postnatal development, the concentration of (48) , which represents a critical period for synaptogenesis and synaptic refinement (49) . The 5-HT 2C receptor is transiently expressed in the cortices from P10 to P28, whereas the 5-HT 2A receptor expression increases progressively from P3 to P21, reaching the adult level. During the early postnatal period, pyramidal cells of layer V of the prefrontal cortex are profoundly depolarized by 5-HT, an effect that is mediated by the activation of the 5-HT 2A receptor. However, 5-HT 2A receptor-induced depolarization declines with increasing age (50, 51) . In light of our results, 5-HT may progressively bind to the 5-HT 2C protomer leading to a switch in signaling pathway activation and downstream membrane depolarization.
The operational model revealed no significant differences in the coupling ability to the G␣ q pathway between membranes expressing 5-HT 2 receptors alone and membranes expressing 5-HT 2 heterodimers. However, heterodimerization may affect the 5-HT 2 receptors signaling in many other ways; in addition to the activation of G␣ q , G␣ i/o , or G␣ 12/13 proteins, activation of phospholipase A 2 , and phospholipase D (ERK1/2 or ␤-arrestindependent pathways) (52, 53) can be mediated by 5-HT 2 receptors. All these pathways could be differentially affected by heterodimers. Interacting proteins like PSD-95, MUPP-1, and RSK2 (54) on 5-HT 2A and 5-HT 2B receptors might have also been affected by the dimerization with the 5-HT 2C receptor. For example, the 5-HT 2C and 5-HT 2B receptors co-expressed in POMC neurons of the arcuate nucleus (11) are involved in feeding behavior but are not necessarily dependent on G q coupling. Additional studies on other signaling pathways should be performed to ascertain putative changes in 5-HT signaling associated with heterodimerization.
Another consequence of the dominant effect of the 5-HT 2C receptor is a putative misleading link between pharmacological brain mapping expression and function of 5-HT 2 receptors. For example, in the Globus pallidus, the expression of 5-HT 2A receptors, revealed by immunolabeling, had previously gone unnoticed due to absent or weak ligand binding. The 5-HT 2A receptor immunostaining of the amygdala complex and in Purkinje cells of the cerebellum (55, 56) was also inconsistent with negative radioligand binding results previously reported (5, 57, 58) . The reason for this expression discrepancy is unclear, but knowing that all these nuclei also express 5-HT 2C receptors (4 -6, 55, 59), a plausible explanation would be a pharmacological shielding of 5-HT 2A by 5-HT 2C receptors, without consequence for the immunocytochemistry detection. More importantly, pharmacological studies targeting 5-HT 2A or 5-HT 2B receptors in a physiological or a pathological context, like schizophrenia, food intake disorders, or depression, should take into account this dominant effect when brain areas of interest (i.e. frontal cortex, hypothalamus, or raphe nucleus, respectively) also express 5-HT 2C receptors (8, 11, 47, 60, 61) . This could lead to a misinterpretation of experimental results due to a mismatch between the consistent expression of 5-HT 2A or 5-HT 2B receptor in a particular nucleus, dedicated to a specific physiological function, and a lack of effect of selective pharmacological compounds. The putative formation of these heterodimers must now be taken into account when analyzing the physiological and/or pathophysiological role of 5-HT in tissues co-expressing 5-HT 2C /5-HT 2A or 5-HT 2C /5-HT 2B receptors.
Experimental procedures
Animals
Male mice (8 -12 weeks old) used in these experiments are in a 129S2/SvPAS background (Charles River, France). Animals were housed in groups of 3-5 per cage. The temperature was maintained at 21 Ϯ 1°C, under 12:12 h light/dark. Food for laboratory mice (SAFE A03, France; 3200 kcal/kg, moisture 12%, proteins 21%, lipids 5%, carbohydrates 52%, fibers 4%, and mineral ash 6%) and water were available ad libitum. Electrophysiological recording and animal care were conducted in accordance with the standard ethical guidelines ("Guide for the Care and Use of Laboratory Animals" from the National Institutes of Health and the European Communities Council European Communities Directive 86/609 EEC). All experiments involving mice were approved by the local ethical committee (number 1170.01).
Plasmid constructs
Human 5-HT 2A , 5-HT 2B , 5-HT 2CINI receptor cDNAs were subcloned into the p513 vector, a derivative of the pSG5 mammalian expression vector (62) , which replicates in SV40 T antigen-expressing cells and drives 5-HT receptor expression under the control of the SV40 early promoter. The C terminus truncated after amino acid 370 for the human 5-HT 2C and amino acid 393 for the human 5-HT 2B receptors (63) was generated by PCR deletion mutagenesis. 5-HT receptor-coding regions were amplified from their respective cDNAs using appropriate sense and antisense primers. The fragments were then subcloned in-frame in either a plasmid encoding C-terminal YFP (Clontech and BD Biosciences), N-terminal FLAG (Clontech and BD Biosciences), or Rluc. The coding regions of all constructs were entirely sequenced.
Cloning of mouse 5-HT 2C receptor cDNA
From the full-length cDNA sequence of 5-HT 2CVNV and 5-HT VNI receptors from mice that we previously reported (60), we selected the VNV-edited isoforms of 5-HT 2C receptor for AAV injections, as VNV has been shown to be the most prevalent in C57BL/6J and 129S1/SvImJ mice (64) . The C terminus of the mouse 5-HT 2CVNV was truncated after amino acid 370.
Cell culture COS-7, HEK293, LMTK Ϫ , and CHO cells were cultured as monolayers in Dulbecco's modified Eagle's medium (DMEM) (Gibco, Invitrogen) supplemented with 10% fetal calf serum (Biowest) and 1% penicillin/streptomycin (Sigma), in 9-cm dishes (Falcon). Cells were incubated at 37°C in a 5% CO 2 atmosphere. Cells were 80% confluent when transfected with 10 g of DNA using nanofectin (PAA), according to the manufacturer's protocol, in an antibiotic-free medium. Four hours later, medium was replaced with fresh medium. Twenty four hours after transfection, cells were incubated in serum-free medium for membrane radioligand binding or trypsinized (trypsin 1ϫ 0.05% EDTA, Invitrogen) and plated onto 24-well plates for IP accumulation.
AAV-mediated local LC or PFC 5-HT 2C⌬Cter expression
Adeno-associated virus (AAV9)-expressing GFP (7.5 ϫ 10 12 virus molecules/ml) and 5-HT 2C⌬Cter (IRES) GFP (8.8 ϫ 10 12 virus molecules/ml) under the control of the synapsin promoter (UNC Vector Core, Dr. R. Jude Samulski, Chapel Hill, NC) were stereotaxically injected into the LC (100 nl) or the PFC (600 nl). Mice were anesthetized with ketamine (50 mg/kg) and xylazine (2 mg/kg) and fixed in a stereotaxic apparatus. A burr hole was drilled above the LC (coordinates: 5.4 mm posterior to bregma, 1 lateral to midline) or the PFC (coordinates: 1.8 mm anterior to bregma, 2 lateral to midline). Stereotaxically guided injections were made through the hole in the dorsal surface of the cranium (3 mm deep for the LC and 1 mm for the PFC). Glass capillary tubes were pulled (HEKA pipette puller PIP5) and tips broken to 40-m diameters. After 4 weeks of recovery and viral expression, the LC and PFC AAV-injected mice were used for electrophysiological or binding experiments, respectively. Proper viral infection was verified by GFP detection on brain-fixed sections.
In vivo electrophysiology of DR 5-HT neurons
Mice were anesthetized with chloral hydrate (400 m/kg; i.p.) and mounted in a stereotaxic frame. Additional anesthesia (50 -100 mg/kg; i.p.) was given as necessary to maintain a full anesthetic state, characterized by the absence of response to a tail pinch. Body temperature was maintained at 37°C throughout the experiments using a thermistor-controlled heating pad (Astro-Med, Elancourt, France). The extracellular recordings of the 5-HT neurons in the DR were performed using singlebarreled glass micropipettes (Stoelting, Dublin, Ireland) pulled on a pipette puller (Narishige, Tokyo, Japan) preloaded with a 2 M NaCl solution. Their impedance typically ranged between 2.5 and 5 megohms. The single-barreled glass micropipettes were positioned 0.2-0.5 mm posterior to the interaural line on the midline and lowered using a hydraulic micropositioner (Kopf Instruments) into the DR, usually attained at a depth between 2.5 and 3.5 mm from the brain surface. To increase the signalto-noise ratio, we used a current amplifier (BAK Electronics, Mount Airy, MD) connected to the active filter Humbug (Quest Scientific, DIPSI, Châtillon, France). The presumed DR 5-HT neurons were then identified according to the criteria of Aghajanian and Vandermaelen (65), i.e. a slow (0.5-2.5 Hz) and regular firing rate and long-duration (2-5 ms) bi-or triphasic extracellular waveform. Neuronal activity was recorded in real time using Spike2 software (Cambridge Electronic Design, Cambridge, UK), which was also used to analyze neurons off line. For all dose-response curves, only one neuron was recorded and tested from each animal. 
H-radioligands and drugs
[ 3 H]IP accumulation assay
Twenty four hours before the experiment, cells were incubated in 24-well plates overnight with 20 nM myo-[ 3 H]inositol diluted in an inositol-free medium (BME, Lonza, Basel, Switzerland). Just before receptor stimulation, medium was replaced by Krebs-Ringer/Hepes buffer (130 mM NaCl, 1.3 mM KCl, 2.2 mM CaCl 2 , 1.2 mM NaH 2 PO 4 , 1.2 mM MgSO 4 , 10 mM Hepes, 10 mM glucose, pH 7.4) supplemented with 20 mM LiCl to prevent IP 1 degradation. Cells were stimulated in duplicate in a final volume of 500 l for 2 h. The experiment was stopped by replacing the stimulation medium with 10 Ϫ3 M formic acid at room temperature for 20 min and at 4°C overnight. Thus, IP 1 accumulated from IP 3 and IP 2 hydrolysis was released from lysed and fixed cells. The accumulated IP 1 was eluted on anion exchange columns (AG-1X8, Bio-Rad) with 0.2 M ammonium formate in 0.1 M formic acid. Scintillation mixture (Ultima Gold XR, PerkinElmer Life Sciences) was added to the eluted [ 3 H]IP sample, and radioactivity was counted in a Beckman Coulter scintillation counter. At least three independent experiments were performed in triplicate.
HTRF IP accumulation
COS-7 cells were transfected with 3 g of DNA (1:1 ratio for co-transfection) in 6-well plates using Genjuice transfectant reagent in complete medium. Twenty four hours later the cells were trypsinized (trypsin 1ϫ 0.05% EDTA; Invitrogen) and plated in 96-well plates (30,000 cells/well). The next day, complete medium was replaced by serum-free medium. The day of the experiment, media were replaced by stimulation buffer with LiCl to prevent IP 1 degradation (NaCl 146 mM, KCl 4.2 mM, MgCl 2 0.5 mM, CaCl 2 1 mM, Hepes 10 mM, glucose 5.5 mM, LiCl 50 mM, pH 7.4). Cells were stimulated during 2 h at 37°C with a different concentration of full and partial agonists, 5-HT and DOI, respectively (10 Ϫ11 to 10 Ϫ6 M in stimulation buffer). Stimulation solution was replaced by lysis buffer (IP one HTRF Kit, Cisbio, France) during 1 h. Lysates were distributed to 384-well plates, and IP was labeled using HTRF reagents. The assay is based on a competitive format involving a specific antibody labeled with terbium cryptate (donor) and IP coupled to d 2 (acceptor). After a 1-h incubation with HTRF reagent, the plate was read using Mithras LB940 plate reader according to the manufacturer's instructions. At least five independent experiments were performed in duplicate.
Operational model
Data obtain in HTRF were transformed in femtomoles of IP per mg of protein per well using a standard dose-response curve. An operational model first described by Black and Leff in 1983 (31) was used to calculate coupling efficiency of each receptor in each condition for full (5-HT) and partial (DOI) agonists. This model allowed us to determine whether the dimerization could affect the coupling efficiency of the complex to the G␣ q /phospholipase C (PLC)/IP pathway. The power of a ligand to activate a specific cellular pathway is represented by the /K A or RA (activity ratio). These values are extracted from the description of Model 1 and Equation 1,
where E m is maximal response; n is slope; K A is equilibrium constant dissociation of the agonist-receptor complex or affinity; is efficacy.
The operational model conditions show that for dose-response curves of unit slope (n ϭ 1), it can be seen that RA reduces to the term E m (/K A ). Ratios of these terms for particular agonists cancel the E m term and are therefore system-independent. A theoretically complete term to describe the power of a ligand to active a cellular pathway is /K A , which incorporates both elements of efficacy and affinity. Considering that the most common difference between systems is receptor density, ratios of /K A account for these and are system-independent measures of the relative capacity of ligands to activate a specific pathway.
Radioligand binding assays on PFC
PFC freshly dissected from mouse brain was homogenized with 50 ml of ice-cold buffer per g of wet tissue containing 50 mM Tris and 5 mM MgCl 2 , pH 7.4. The homogenate was centrifuged for 20 min at 15,000 ϫ g. The pellet was resuspended and centrifuged under the same condition three times. Membrane preparations were resuspended in binding buffer to obtain a final concentration of 1 mg of protein/well. Radioligand binding assays were set up in a 96-well plate (1.2 ml/well capacity) using 5 nM [ 3 H]mesulergine (PerkinElmer Life Sciences) and increasing concentrations of MDL100907 for 60 min at room temperature. [ 3 H]Mesulergine ligand choice was based on the selective 5-HT 2 receptor-binding properties. This allows for the simultaneous measurement of 5-HT 2A and 5-HT 2C receptor expression, using the specific cold antagonists.
Membrane radioligand binding assay
Membrane binding assays were performed on transfected cells plated in 10-cm dishes. Cells were first washed with PBS, scraped into 10 ml of PBS on ice, and then centrifuged for 5 min at 1000 ϫ g. Cell pellets were dissociated and lysed in 2 ml of binding buffer (50 mM Tris-HCl, 10 mM MgCl 2 , 0.1 mM EDTA, pH 7.4) and centrifuged for 30 min at 10,000 ϫ g. Membrane preparations were then resuspended in binding buffer to obtain a final concentration of 0.2-0.4 mg of protein/well. Aliquots of membrane suspension (200 l/well) were incubated with 25 l/well of 3 H-radioligand at a final concentration near the K D value, diluted in binding buffer and 25 l/well of increasing concentrations of homologous or heterologous compound (from 10 Ϫ11 to 10 Ϫ5 M, diluted in binding buffer) in 96-well plates for 60 min at room temperature. Membranes were harvested by rapid filtration onto Whatman GF/B glass fiber filters (Brandell) pre-soaked with cold saline solution and washed three times with cold saline solution to reduce nonspecific binding. Filters were placed in 6-ml scintillation vials and allowed to dry overnight. The next day, 4 ml of scintillation mixture were added to the samples, which were counted as before. Data in disintegrations/min were converted to femtomoles and normalized to protein content (ranging from 0.1 to 1 mg/well). At least three independent experiments were performed in duplicate. before the experiment, the cells were incubated in serum-free medium overnight. The next day, the medium was replaced by 400 l/well of Krebs-Ringer/Hepes buffer (130 mM NaCl, 1.3 mM KCl, 2.2 mM CaCl 2 , 1.2 mM NaH 2 PO 4 , 1.2 mM MgSO 4 , 10 mM Hepes, 10 mM glucose, pH 7.4). Then, 50 l of [ 3 H]mesulergine were diluted in Krebs-Ringer/Hepes buffer at a final concentration between half the K d and the K d for each 5-HT receptor. The radioligand was competed with 50 l of increasing concentrations of non-radioactive ligand, also diluted in Krebs-Ringer/Hepes buffer. Cells were then incubated for 30 min at room temperature and then washed twice on ice with cold PBS. Washed cells were solubilized by the addition of 500 l of SDS 1%. The next day, 4 ml of scintillation mixture were added to the samples, and the radioactivity was counted using a scintillation counter (Beckman Coulter). Data in disintegrations/min were converted to femtomoles and normalized to protein content (0.2-0.4 mg of protein/well). At least three independent experiments were performed in duplicate.
Co-immunoprecipitation
FLAG-tagged 5-HT 2B and 5-HT 2C receptor cDNA constructs were transfected in COS-7 cells with various combinations of YFP-tagged 5-HT 2 receptors. After 48 h, cells were washed in PBS, sonicated, and solubilized in lysis buffer (75 mM Tris, 2 mM EDTA, 12 mM MgCl 2 , 10 mM CHAPS, protease inhibitor mixture EDTA free, pH 7.4) during 12 h at 4°C. Lysates were centrifuged at 12,000 ϫ g during 30 min at 4°C. Immunoprecipitations were performed using EZview Red FLAG M2 affinity gel (Sigma) according to the manufacturer's recommendations. Immunoprecipitated proteins and 100 g of total proteins were combined with Laemmli buffer, heated at 70°C for 10 min, and run on 10% BisTris gel. Immunoblots were probed with rabbit anti-GFP (Abcam) or anti-FLAG rabbit (Sigma) antibodies diluted 1:2000, and immunoreactivity was revealed using secondary antibody coupled to 680-nm fluorophores using the Odyssey LI-COR infrared fluorescent scanner.
BRET assays
BRET assays were performed according to published methods (66) . Briefly, HEK cells (5 ϫ 10 5 per well of a 6-well plates) were transfected with 30 -100 ng of plasmid DNA coding for the BRET donor (5-HT 2 -Luc) and increasing amounts of BRET acceptor plasmids (5-HT 2 -YFP; 100 -4000 ng per well). Twenty four hours after transfection, cells were washed in PBS, detached using 10 mM EDTA in PBS, centrifuged (1400 ϫ g for 5 min), resuspended in Hanks'-balanced salt solution, and distributed in 96-well plates (PerkinElmer Life Sciences plates; 10 5 cells per well). After addition of the luciferase substrate, coelenterazine-h (5 Mfinalconcentration),luminescence,andfluorescence were measured simultaneously (at 485 and 530 nm, respectively) in a Mithras LB940 plate reader. The BRET ratio was calculated as ((emission at 530 nm/emission at 485 nm) Ϫ (background at 530 nm/background at 485 nm)), where background corresponds to signals in cells expressing the Rluc fusion protein alone under the same experimental conditions. For better readability, results were expressed in milli-BRET units (mBRET), with 1 mBRET corresponding to the BRET ratio multiplied by 1000. BRET ratios were plotted as a function of ((YFP Ϫ YFP0)/YFP0)/(Rluc/Rluc0), where YFP is the fluorescence signal at 530 nm after excitation at 485 nm, and Rluc is the signal at 485 nm after addition of coelenterazine-h. YFP0 and Rluc0 correspond to the same values in cells expressing the Rluc fusion protein alone.
Receptor cell-surface export analysis
To study the putative impact of 5-HT 2C receptor co-expression on 5-HT 2A or 5-HT 2B receptor targeting at the cell surface, COS-7 cells were transiently co-transfected with 5-HT 2C -mCherry or 5-HT 2A -mCherry and a construct coding for 5-HT 2A or 5-HT 2B displaying the FLAG epitope at the N terminus and fused C-terminally to the YFP. Empty vector, p513, was used to maintain identically the total amount of transfected DNA. 48 h after transfection, cells were harvested, washed in PBS, and fixed in 4% paraformaldehyde. The expression of each receptor was assessed by measuring GFP and mCherry fluorescence using a Miltenyi MacsQuant VYB cytometer. These determinations allowed us to quantify the amount of singletransfected cells (less than 5%) of double-transfected cells (60%) and show that these values are identical whatever the combination of transfected receptors. To determine cell surface 5-HT 2A or 5-HT 2B expression, cell aliquots were stained with a primary antibody directed against the extracellular FLAG epitope conjugated to Pacific Blue dye (Cell Signaling) following the manufacturer's protocol. Pacific Blue and YFP signals correspond to surface and total FLAG-5-HT 2 -YFP receptors. Cells expressing both GFP and mCherry were analyzed for Pacific Blue signal. Ratio of cell-surface receptors over total were obtained (mean of Pacific Blue signal/mean of GFP) for each condition and normalized as percentage of 5-HT 2A or 5-HT 2B receptor alone (single transfection), see Doly et al. (67) .
Data analysis
Binding data were analyzed using the iterative non-linear regression model (GraphPad Prism 6.0). This allowed the calculation of inhibition constants (K i ) and the maximal number of sites (B max ). All values represent the average of independent experiments Ϯ S.E. (n ϭ number of experiments as indicated in the text).
Statistics
Comparisons between groups were performed using Student's unpaired t test, or one-or two-way ANOVA with Bonferroni's post hoc test were used depending on the experiment. Significance was set at p Ͻ 0.05 receptors. 
